STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN

STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN

Dades bibliogràfiques
Autors principals:	Walton, R, Russell, R, Alberti, K, Clark, M, Potts, J, Bisaz, S, Fleisch, H
Format:	Journal article
Idioma:	English
Publicat:	1974

Ítems similars

Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
per: Walton, R, et al.
Publicat: (1974)

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
per: Walton, R, et al.
Publicat: (1975)

Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
per: Walton, R, et al.
Publicat: (1976)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
per: Russell, R, et al.
Publicat: (1979)

Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
per: Smith, R, et al.
Publicat: (1973)

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
per: Russell, R, et al.
Publicat: (1975)

ABNORMAL RESPONSES TO EHDP TREATMENT OF PAGETS-DISEASE
per: Smith, R, et al.
Publicat: (1977)

Diphosphonates in Paget's disease.
per: Russell, R, et al.
Publicat: (1974)

Diphosphonates and polyphosphates in medicine
per: Russell, R
Publicat: (1975)

Synthesis of Four Enantiomers of (1-Amino-3-Hydroxypropane-1,3-Diyl)Diphosphonic Acid as Diphosphonate Analogues of 4-Hydroxyglutamic Acid
per: Liwia Lebelt, et al.
Publicat: (2022-04-01)

Microstructure and Phase Characterization of Alkali-Activated Slag–Fly Ash Materials with Tetrasodium of 1-Hydroxy Ethylidene-1, 1-Diphosphonic Acid (HEDP·4Na)
per: Bo Zhou, et al.
Publicat: (2024-05-01)

Treatment of myositis ossificans progressiva with a diphosphonate.
per: Russell, R, et al.
Publicat: (1972)

Complexation of 1-Hydroxyethylidene-1,1-Diphosphonic Acid (HEDP) and Manganese(II) in Aqueous Solution
per: О.V. Bogatyrev, et al.
Publicat: (2016-03-01)

Proceedings: Background to the use of diphosphonates as bone scanning agents.
per: Russell, R, et al.
Publicat: (1975)

Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
per: Gray, R, et al.
Publicat: (1987)

Treatment of [99mTc]Tc‐hydroxy‐diphosphonate ([99mTc]Tc‐HDP) extravasation using hyaluronidase
per: Kevin R. Doornhof, et al.
Publicat: (2024-08-01)

The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats
per: Russell, R, et al.
Publicat: (1970)

Diaquabis{[1-hydroxy-2-(1H-imidazol-3-ium-1-yl)ethane-1,1-diyl]bis(hydrogen phosphonato)}manganese(II)
per: Yu Zhang, et al.
Publicat: (2009-12-01)

1-(5-Hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethan-1-one
per: Bingjing Liu, et al.
Publicat: (2010-06-01)

catena-Poly[zinc(II)-&#956;3-{hydrogen [1-hydroxy-2-(3-pyridinio)ethane-1,1-diyl]diphosphonato}]
per: Xihe Huang, et al.
Publicat: (2010-01-01)

Impact and mechanism of bisphosphonate depressant 1-hydroxypropane-1,1-diphosphonic acid on flotation decalcification of dolomite-rich magnesite ore
per: Wengang Liu, et al.
Publicat: (2024-07-01)

1-Phenyl-1-[(1-phenylethyl)sulfonylmethylsulfonyl]ethane
per: Jing-tao Liu, et al.
Publicat: (2009-12-01)

Hyperphosphatemia and Cardiovascular Disease
per: Chao Zhou, et al.
Publicat: (2021-03-01)

Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1
per: Hualong Zang, et al.
Publicat: (2024-01-01)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
per: Ju-Young Moon, et al.
Publicat: (2015-03-01)

Synthesis and structure of heterometallic multiligand Ge(IV) - 3d-metals complexes with 1-hydroxyethane-1,1-diphosphonic acid and 1,10-phenanthroline
per: Kyrylo Tsymbaliuk, et al.
Publicat: (2024-12-01)

Crystal structure of 1-(6-hydroxy-2-phenylbenzofuran-5-yl)ethan-1-one, C16H12O3
per: Olomola Temitope O., et al.
Publicat: (2020-10-01)

1-(Pyrrolidin-1-yl)ethan-1-iminium chloride
per: Rylan Artis, et al.
Publicat: (2023-09-01)

Disodium 4,5,6-trihydroxybenzene-1,3-disulfonate dihydrate
per: U. Beginn, et al.
Publicat: (2010-10-01)

Crystal structure of 1-(4-chloro-2-hydroxy-5-iodophenyl)ethan-1-one, C8H6ClIO2
per: Mphahlele Malose J.
Publicat: (2019-12-01)

Crystal structure of (E)-1-(2-hydroxy-3-{[2-hydroxybenzylidene]amino}phenyl)ethan-1-one, C15H13NO3
per: Yang Yu-Hua, et al.
Publicat: (2017-11-01)

Clinical Characteristics and Outcomes of Hyperphosphatemia in Patients with Chronic Kidney Disease Stages 1–2
per: Chao Xie, et al.
Publicat: (2024-07-01)

Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy
per: Walton, K, et al.
Publicat: (1985)

Hyperphosphatemia in chronic kidney disease
per: S. A. Martynov, et al.
Publicat: (2019-10-01)

Optimizing 1-hydroxyethylidene-1,1-diphosphonic acid and mechanically-activated iron ore tailings to prepare low-cost and retarded magnesium oxysulfate cement
per: Huihui Liang, et al.
Publicat: (2022-12-01)

New amino bisphosphonate compound for skeletal imaging: Comparison study with methylenediphosphonic acid (MDP) and (1-hydroxyethane-1,1-diyl) diphosphonic acid (HEDP)
per: Assaad Thaer
Publicat: (2016-03-01)

3,3′-[(1E,1′E)-Hydrazine-1,2-diylidenebis(ethan-1-yl-1-ylidene)]bis(4-hydroxy-6-methyl-2H-pyran-2-one)
per: Abouelhaoul El Alami, et al.
Publicat: (2019-10-01)

(E)-1-(4-Bromophenyl)ethan-1-one semicarbazone
per: Hoong-Kun Fun, et al.
Publicat: (2009-07-01)

(E)-1-(4-Fluorophenyl)ethan-1-one semicarbazone
per: Hoong-Kun Fun, et al.
Publicat: (2009-07-01)

Preparation of anti-reversion agent disodium hexamethylene-1,6-dithiosulfate dihydrate
per: LI Tian-yu1, HOU Wen-jie2, SHI Yun-hai1, YU Tao1
Publicat: (2024-01-01)